Interrelations Between Plant Treaty, UPOV, WIPO, Farmers’ Rights – Do They Equate? 02/04/2015 by Catherine Saez, Intellectual Property Watch 6 Comments Farmers’ rights are enshrined in the international plant treaty. However, their implementation is an ongoing issue, which the plant treaty is seeking to address by looking at the interrelation that might exist with other international instruments. Separately, civil society is asserting that the World Intellectual Property Organization favours the International Union for the Protection of New Varieties of Plants (UPOV) in its technical assistance. But the WIPO Director General countered that this is decidedly not the case.
WHO Issues Guideline For Manufacturers Of Generic Hepatitis C Medicine 02/04/2015 by Catherine Saez, Intellectual Property Watch 3 Comments The World Health Organization has issued a guidance document on the design of bioequivalence studies for a leading hepatitis C medicine. Generic drug companies seeking prequalification by the WHO need to demonstrate that their generic version is equivalent to the originator drug.
EPO Backs Patents On Conventional Plants: Broccoli, Tomato Cases Decided 01/04/2015 by Catherine Saez, Intellectual Property Watch 12 Comments The highest court of the European Patent Office has declared that plants or seeds obtained through conventional breeding methods are patentable.
Panel: Open Data, Open Access, And Open Education – Key To Open Innovation? 31/03/2015 by Elena Bourtchouladze for Intellectual Property Watch 1 Comment Intellectual property stimulates creativity but at the same time holds back innovation, speakers said at a recent event on open innovation and alternative business models. The roundtable looked a range of models, such as open source and open data, and their advantages, to “all rights reserved” protection.
Supplier of Essential Medicines Supports TRIPS Waiver For Least-Developed Countries 30/03/2015 by Catherine Saez, Intellectual Property Watch 5 Comments The IDA Foundation, a worldwide supplier of essential medicines to low-and medium income countries, has backed the request by least-developed countries to extend a waiver that allows them to forfeit the obligations to protect intellectual property on pharmaceutical products. UNITAID, the UN-related drug purchasing mechanism, also issued a statement in support of the extension. The request is expected to be discussed at the World Trade Organization in June.
How The Leaked TPP ISDS Chapter Threatens Intellectual Property Limitations and Exceptions 26/03/2015 by Intellectual Property Watch 6 Comments By Prof. Sean Flynn, Associate Director, Program on Information Justice and Intellectual Property (PIJIP), American University Washington College of Law Reposted with permission from Infojustice.org, original here. I released a statement earlier today opining that the today’s leak of the Investor State Dispute Settlement (ISDS) chapter proposed for the Trans Pacific Partnership (TPP) agreement (available […]
Busy Year At WTO: 20th Anniversary, Doha Round, Dispute Settlement Overload 26/03/2015 by Catherine Saez, Intellectual Property Watch 1 Comment This year is an auspicious moment for the World Trade Organization and the multilateral trading system, WTO Director General Roberto Azevêdo told journalists today. In particular, he said, the WTO, after a hiatus last year, is implementing the results of the 2013 Bali agreement on trade facilitation and finalising work on the work programme to conclude the Doha Round of trade liberalisation negotiations.
Indian Draft Pesticides Bill Contains TRIPS-Plus Data Exclusivity, Indian Pharma Says 26/03/2015 by Catherine Saez, Intellectual Property Watch 3 Comments India is considering legislation on pesticides containing data exclusivity provisions that would raise the level of intellectual property protection above the minimum required by international trade agreements and could act as a precursor for pharmaceutical products in the country, a leading Indian industry representative warned this week. India is sensitive to restrictions on the use of marketing data of patented pharmaceuticals as it is seen as the world leader in generic medicines, which use such data.
Slifer Named USPTO Deputy Director 25/03/2015 by Intellectual Property Watch Leave a Comment A veteran technology industry and innovation patent attorney has been named the new deputy director has been named at the United States Patent and Trademark Office (USPTO).
Patent On Conventional Plant Dismissed For Lack Of Novelty, Firm Says 24/03/2015 by Intellectual Property Watch Leave a Comment The District Court of The Hague (Netherlands) ruled last week that a patent for red radish plants is invalid in the Netherlands for lack of novelty but did not rule on the fact that the particular plant was bred using essential biological processes. The case, between two Dutch companies, related to red radish sprouts on which one company held a patent.